Lithium succinate
Jump to navigation
Jump to search
 | |
| Gene therapy | |
|---|---|
| Clinical data | |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C4H5LiO4 |
| Molar mass | 124.02 g/mol |
Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]
References
- ↑ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. PMID 8358107.
- ↑ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. PMID 9259500.
Categories:
- CS1 maint: Multiple names: authors list
- Articles with short description
- Infobox-drug molecular-weight unexpected-character
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Salts and esters of carboxylic acids